A detailed history of Arrowstreet Capital, Limited Partnership transactions in Zynex Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 314,353 shares of ZYXI stock, worth $2.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
314,353
Previous 574,887 45.32%
Holding current value
$2.56 Million
Previous $7.11 Million 58.8%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$8.63 - $12.56 $2.25 Million - $3.27 Million
-260,534 Reduced 45.32%
314,353 $2.93 Million
Q4 2023

Feb 14, 2024

BUY
$7.1 - $10.89 $3.32 Million - $5.1 Million
467,909 Added 437.39%
574,887 $6.26 Million
Q3 2023

Nov 14, 2023

BUY
$6.95 - $9.89 $611,141 - $869,667
87,934 Added 461.74%
106,978 $856,000
Q2 2023

Aug 14, 2023

BUY
$8.59 - $14.56 $36,387 - $61,676
4,236 Added 28.61%
19,044 $183,000
Q1 2023

May 15, 2023

BUY
$9.53 - $16.8 $141,120 - $248,774
14,808 New
14,808 $178,000
Q4 2020

Feb 12, 2021

SELL
$11.65 - $17.94 $159,605 - $245,778
-13,700 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$12.98 - $25.98 $177,826 - $355,926
13,700 New
13,700 $239,000
Q2 2020

Aug 12, 2020

SELL
$9.06 - $23.49 $1.18 Million - $3.06 Million
-130,213 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$7.2 - $13.09 $500,565 - $910,056
-69,523 Reduced 34.81%
130,213 $1.44 Million
Q4 2019

Feb 13, 2020

SELL
$6.94 - $11.37 $19,432 - $31,835
-2,800 Reduced 1.38%
199,736 $1.57 Million
Q3 2019

Nov 14, 2019

BUY
$6.69 - $9.65 $1.05 Million - $1.52 Million
157,361 Added 348.34%
202,536 $1.93 Million
Q2 2019

Aug 14, 2019

BUY
$4.23 - $10.66 $191,090 - $481,565
45,175 New
45,175 $406,000

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $304M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.